3rd Qtr Financial Results
- Thread starter anonymous
- Start date
-
- Tags
- None
What kind of a life do you lead on this board 24/7. Pathetic!! You really need to get some help. Electro shock is a good option for you.
You seem hurt, Karen. May I recommend that you accuse an infant of crying too loudly? That will make you feel better.
Woah, Karen, words hurt. I thought we were friends. I apologize. Let’s make up. Post the file, so we can all take a look at that amazing business plan.
Never a Clinical discussion on this board.
Guess there is no Clinical to discuss.
Snake oil ?
Prove wrong.
Guess there is no Clinical to discuss.
Snake oil ?
Prove wrong.
Thanks, Karen, for the continuous level of dumb that you spew. Give us your business plans, and we’ll oblige.
Is this the guy that spews about trailer trash, Old Milwaukee beer cans, and the smell ?
What a moron.
Do you ever feel like the walls are closing in on you Karen? I thought so.
Investors are starting to flock to the high-tech BioScience arena, and clearly Esperion could be a beneficiary of this investment shift. Opportunities like this are the ones that deliver long-term performance results. The clinical unmet need is a problem seeking a solution. Primary prevention is where the money is at, right place at the right time and a little bit lucky. Some will look back and say I should’ve, they lament the past and fail to capitalize on the future.
This is playing out right before our eyes. High-tech bioscience Stocks are a huge beneficiary of lower interest rates, not to mention the massive value put on the benefits of improved health. 2024 should be a banner year as everything is falling into place. It’s good to have long term options in the bank as a reward for hard work and benefit to society.
Huge failure alert! The quality of people working at this boileroom operation is on par with a road crew picking up trash on the interstate.